Transgenic analysis of thymocyte signal transduction

Nature Reviews Immunology

Volumn 2, Issue 1, 2002, Pages 20-27

  Cantrell, Doreen A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; BACTERIAL TOXIN; RAS PROTEIN;

CELL PROLIFERATION; CELL SURVIVAL; DOMINANT INHERITANCE; DOMINANT NEGATIVE MUTANT; GAIN OF FUNCTION MUTANT; GENE FUNCTION; GENE MAPPING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOUSE; MUTANT; NONHUMAN; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; THYMOCYTE; THYMUS; TRANSGENICS; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; GENETICS; IMMUNOLOGY; MUTATION; TRANSGENIC MOUSE;

ANIMALS; BACTERIAL TOXINS; CELL DIFFERENTIATION; CELL DIVISION; GTP-BINDING PROTEINS; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0036359608     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri703     Document Type: Review

References (85)

1. Crompton, T., Gilmour, K. C. & Owen, M. J. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell 86, 243-251 (1996).
2. Pallard, C. et al. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 10, 525-535 (1999).
3. Perlmutter, R. M. & Alberola-Ila, J. The use of dominant-negative mutations to elucidate signal transduction pathways in lymphocytes. Curr. Opin. Immunol. 8, 285-290 (1996).
4. Rincon, M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13, 339-345 (2001). Two excellent reviews: reference 3 covers most of the key experiments using transgenesis to look at the function of SRC kinases and Ras GTPases in the thymus; reference 4 is a comprehensive analysis of how MAP kinases control lymphocyte biology.
5. Allen, J. M., Forbush, K. A. & Pedmutter, R. M. Functional dissection of the Lck proximal promoter. Mol. Cell. Biol. 12, 2758-2768 (1992).
6. Zhumabekov, T., Corbella, P., Tolaini, M. & Kioussis, D. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185, 133-140 (1995).
7. Ellmeier, W., Sawada, S. & Littman, D. R. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu. Rev. Immunol. 17, 523-554 (1999).
8. Clevedey, S., Henning, S. & Cantrell, D. Inhibition of Rho at different stages of thymocyte development gives different perspectives on Rho function. Curr. Biol. 9, 657-660 (1999).
9. lck with the pre-T cell receptor during thymocyte development. Eur. J. Immunol. 30, 8-18 (2000).
10. Gomez, M., Tybulewicz, V. & Cantrell, D. A. Control of pre-T cell proliferation and differentiation by the GTPase Rac-1. Nature Immunol. 1, 348-352 (2000).
11. van Weeren, P. C., de Bruyn, K. M., de Vries-Smits, A. M., van Lint, J. & Burgering, B. M. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273, 13150-13156 (1998).
12. Garcia-Paramio, P., Cabrerizo, Y., Bornancin, F. & Parker, P. J. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation. Biochem. J. 333, 631-636 (1998).
13. Kuo, C. T. & Leiden, J. M. Transcriptional regulation of T lymphocyte development and function. Annu. Rev. Immunol. 17, 149-187 (1999).
14. Voll, R. E. et al. NF-κB activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 13, 677-689 (2000).
15. + thymocytes. J. Immunol. 165, 5004-5010 (2000).
16. Pearson, R. & Weston, K. c-Myb regulates the proliferation of immature thymocytes following β-selection. EMBO J. 19, 6112-6120 (2000).
17. Taylor, D., Badiani, P. & Weston, K. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev. 10, 2732-2744 (1996).
18. Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. & Strasser, A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718 (1998).
19. Newton, K., Harris, A. W. & Strasser, A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19, 931-941 (2000). References 18 and 19 show that the adaptor FADD/MORT1 induces pro-apoptopic cell-death responses but, in parallel, can control T-cell proliferation.
20. Newton, K., Kurts, C., Harris, A. W. & Strasser, A. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells. Curr. Biol. 11, 273-276 (2001).
21. Genot, E., Cleverley, S., Henning, S. & Cantrell, D. Multiple p21 ras effector pathways regulate nuclear factor of activated T cells. EMBO J. 15, 3923-3933 (1996).
22. Genot, E. & Cantrell, D. A. Ras regulation and function in lymphocytes. Curr. Opin. Immunol. 12, 289-294 (2000).
23. Acuto, O. & Cantrell, D. T cell activation and the cytoskeleton. Annu. Rev. Immunol. 18, 165-184 (2000).
24. Cantrell, D. Phosphoinositide 3-kinase signalling pathways. J. Cell Sci. 114, 1439-1445 (2001).
25. Cantrell D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. (in the press)
26. Ahmed, N. N. et al. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 8, 1957-1963 (1993).
27. Dufner, A., Andjelkovic, M., Burgering, B. M., Hemmings, B. A. & Thomas, G. Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor4E-binding protein 1 phosphorylation. Mol. Cell. Biol. 19, 4525-4534 (1999).
28. L levels in vivo. J. Exp. Med. 191, 1721-1734 (2000).
29. Parsons, M. J. et al. Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. J. Immunol. 167, 42-48 (2001).
30. Astoul, E., Watton, S. & Cantrell, D. A. The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 145, 1511-1520 (1999).
31. Mombaerts, P., Anderson, S. J., Perlmutter, R. M., Mak, T. W. & Tonegawa, S. An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity 1, 261-267 (1994).
32. Iritani, B. M., Alberola-Ila, J., Forbush, K. A. & Perimutter, R. M. Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. Immunity 10, 713-722 (1999).
33. + thymocytes. Proc. Natl Acad. Sci. USA 93, 4683-4687 (1996).
34. Anderson, S. J., Levin, S. D. & Perlmutter, R. M. Protein tyrosine kinase p56lck controls allelic exclusion of T-cell receptor β-chain genes. Nature 365, 552-554 (1993).
35. Henning, S. W. & Cantrell, D. A. p56lck signals for regulating thymocyte development can be distinguished by their dependency on Rho-function. J. Exp. Med. 188, 931-939 (1998). This reference, and reference 32, show that the signals that control pre-T-cell proliferation, differentiation and the processes of allelic exclusion are distinct.
36. Costello, P. S., Clevedey, S. C., Galandrini, R., Henning, S. W. & Cantrell, D. A. The GTPase rho controls a p53-dependent survival checkpoint during thymopoiesis. J. Exp. Med. 192, 77-85 (2000).
37. Corre, I., Gomez, M., Vielkind, S. & Cantrell, D. The GTPase RhoA regulates preTCR and αβTCR mediated responses. J. Exp. Med. (in the press).
38. Lamarche, N. et al. Rac and Cdc42 induce actin polymenzation and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87, 510-529 (1997).
39. Bishop A. L. & Hall A. Rho GTPases and their effector proteins. Biochem. J. 348, 241-255 (2000).
40. + thymocytes. Nature 374, 474-477 (1995).
41. Fischer, K. D. et al. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8, 554-562 (1998).
42. Turner, M. et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7, 451-460 (1997).
43. Strasser, A., Harns, A. W. & Cory, S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889-899 (1991).
44. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339 (1994).
45. Strasser, A., Harris, A. W., Huang, D. C. S., Krammer H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
46. - T cell progenitors. Int. Immunol. 9, 1291-1301 (1997).
47. ven Freeden-Jeffry, U., Solvason, N., Howard, M. & Murray, R. The earliest T lineage-commited cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7, 147-154 (1997).
48. -/- mice. Cell 89, 1011-1019 (1997).
49. Akashi, K., Kondo, M., ron Freeden-Jeffry, U., Murray, R. & Weissman I. L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033-1041 (1997). References 46-48 show that developmental defects associated with loss of IL-7 signals in the thymus can be partially rescued by ectopic expression of Bcl-2; therefore, indicating that a principal function for IL-7 in T-cell development is the control of cell survival.
50. Gallandnni, R., Henning, S. & Cantrell, D. A. Different functions for the GTPase Rho in prothymocytes and late pre-T cells. Immunity 7, 163-174 (1997).
51. von Boehmer, H. et al. Pleiotropic changes controiled by the pre-T-cell receptor. Curr. Opin. Immunol. 11, 135-142 (1999).
52. Irving, B. A., Alt, F. W. & Killeen, N. Thymocyte development in the absence of pre-T cell receptor extracellular immunoglobulin domains. Science 280, 905-908 (1998).
53. Wiest, D. L., Berger, M. A. & Carleton, M. Control of early thymocyte development by the pre-T cell receptor complex: a receptor without a ligand? Semin. Immunol. 11, 251-262 (1999).
54. -/- mice by anti-CD3ε antibody treatment or with transgenes encoding activated Lck or tailless pTα. Immunity 6, 703-714 (1997).
55. O'Shea, C. C., Thornell, A. P., Rosewell, I. R., Hayes B. & Owen, M. J. Exit of the pre-TCR from the ER/cis-Golgi is necessary for signaling differentiation, proliferation, and allelic exclusion in immature thymocytes. Immunity 7, 591-599 (1997).
56. Saint-Ruf, C. et al. Different initiation of pre-TCR and γδ TCR signalling. Nature 406, 524-527 (2000).
57. Gibbons, D. et al. The biological activity of natural and mutant pTα alleles. J. Exp. Med. 194, 695-704 (2001).
58. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).
59. - T cells: half-life and survival signals in the absence of major histocompatibility complex class II molecules. J. Exp. Med. 191, 355-364 (2000).
60. Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity 12, 537-546 (2000).
61. Seddon, B., Legname, G., Tomlinson, P. & Zamoyska, R. Long-term survival but impaired homeostatic proliferation of naive T cells in the absence of p56lck. Science 290, 127-131 (2000). Pioneering studies that set the standard for how to use tetracycline-controlled expression vectors to probe the role of signalling molecules in T-cell development and peripheral T-cell proliferation and survival.
62. Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G. & Evan, G. I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686-1690 (1995).
63. Pelengaris, S., Littlewood, T., Khan, M., Elia, G. & Evan, G. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3, 565-577 (1999).
64. Kohn, A. D. et al. Construction of a conditionally active version of the senne/threonine kinase Akt. J. Biol. Chem. 273, 11937-11943 (1998).
65. Mak, T. W., Penninger, J. M. & Ohashi, P. S. Knockout mice: a paradigm shift in modern immunology. Nature Rev. Immunol. 1, 11-19 (2001).
66. Le, Y. & Sauer, B. Conditional gene knockout using Cre recombinase. Mol. Biotechnol. 17, 260-275 (2001).
67. Metzger, D. & Chambon, P. Site- and time-specific gene targeting in the mouse. Methods 24, 71-80 (2001).
68. Chaffin, K. E. et al. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9, 3821-3829 (1990).
69. Chaffin, K. E. & Perlmutter, R. M. A pertussis toxin-sensitive process controls thymocyte emigration. Eur. J. Immunol. 21, 2565-2573 (1991).
70. Henning, S., Galandrini, R., Hall, A. & Cantrell, D. A. The GTPase Rho has a critical regulatory role in thymocyte development. EMBO. J. 16, 2397-2407 (1997).
71. Swan K. A. et al. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14, 276-285 (1995).
72. Hogquist, K. RasGRP: the missing link for Ras activation in thymocytes. Trends Immunol. 22, 69 (2001).
73. Zwartkruis, F. J. & Bos, J. L. Ras and Rap1: two highly related small GTPases with distinct function. Exp. Cell Res. 253, 157-165 (1999).
74. O'Shea, C. C., Crompton, T., Rosewell, I. R., Hayday, A. C. & Owen, M. J. Raf regulates positive selection. Eur. J. Immunol. 26, 2350-2355 (1996).
75. Turner, H. et al. Rac-1 regulates nuclear factor of activated T cells (NFAT) C1 nuclear translocation in response to Fcε receptor type 1 stimulation of mast cells. J. Exp. Med. 188, 527-537 (1998).
76. Alberola-Ila, J., Forbush, K. A., Seger, R., Krebs, E. G. & Perlmutter, R. M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373, 620-623 (1995).
77. Alberola-Ila, J., Hogquist, K. A., Swan, K. A., Bevan, M. J. & Perlmutter R. M. Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184, 9-18 (1996).
78. Pages, G. et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374-1377 (1999). The MAP kinases Erk1 and Erk2 are generally thought to have redundant functions; however, this paper shows that loss of Erk1 cannot be compensated for by Erk2 during T-cell maturation.
79. Lck Y505F mutation in CD45-defcient mice rescues thymocyte development. Mol. Cell. Biol. 19, 4200-4208 (1999).
80. Sohn, S. J., Forbush, K. A., Pan, X. C. & Perlmutter, R. M. Activated p56lck directs maturation of both CD4 and CD8 single-positive thymocytes. J. Immunol. 166, 2209-2217 (2001).
81. Genot, E. M., Parker, P. J. & Cantrell, D. A. Analysis of the role of protein kinase C-α, -ε, and -ζ in T cell activation. J. Biol. Chem. 270, 9833-9839 (1995).
82. Parekh, D. B., Ziegler, W. & Parker, P. J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19, 496-503 (2000).
83. Matthews, S. A., Rozengurt, E. & Cantrell, D. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191, 2075-2082 (2000).
84. Matthews, S. A., Rozengurt, E. & Cantrell, D. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cμ. J. Biol. Chem. 274, 26543-26549 (1999).
85. Waldron, R. T. et al. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J. Biol. Chem. 276, 32606-32615 (2001).